Matches in SemOpenAlex for { <https://semopenalex.org/work/W2896941213> ?p ?o ?g. }
Showing items 1 to 75 of
75
with 100 items per page.
- W2896941213 abstract "Background and Purpose: The availability of direct-acting oral anticoagulants (DOACs) for nonvalvular atrial fibrillation (NVAF) and venous thromboembolism (VTE) has changed the therapeutic landscape of anticoagulation therapy, but the guideline-based recommendation of anticoagulation therapy for the acute stroke patients with VTE is unclear. Our aim of this study is to survey clinical characteristics of acute stroke patients with VTE in new treatment paradigms including DOACs. Methods: Subjects were acute stroke patients within 7 days from onset with VTE detected by enhanced CT and/or ultrasound of leg veins. VTE evaluation was performed for the patients as follows; presence of right-to-left shunts by transcranial Doppler, elevation of D-dimer, and suspected embolic stroke of undetermined source. We analyzed the following information: 1) the prevalence of VTE among acute stroke patients, 2) clinical information of VTE (i.e. subtype and symptom of VTE), 3) treatment details for stroke and VTE, 4) hemorrhagic complication after VTE treatment. Results: From October 2012 to June 2017, we registered 1077 acute stroke patients. We underwent the VTE evaluation for 226 patients (21%). Of them, 65 patients (39 female, mean age of 76 years, 6% of all patients, and 29% of patients with examination) had VTE (deep vein thrombosis (DVT); 52, pulmonary embolisms (PE); 2, DVT+PE; 11). In 65 patients with VTE, ischemic stroke was 60 cases. Antiplatelet agents were given for 35 of these 60 cases before starting therapy for VTE. Medications for VTE were as follows; 29 cases with DOACs, 14 with warfarin, 7 with warfarin following heparin, and 9 with heparin alone. Hemorrhagic complication occurred in 3 of 60 case of ischemic stroke with VTE (5%). One case had intraventricular hemorrhage after starting DOAC following 200mg aspirin, and muscle hematoma was found in the other two cases using warfarin following heparin. Conclusions: Prevalence of VTE was 6% of acute stroke patients in our preliminary survey. After medication for acute ischemic stroke with VTE, 5% of them had hemorrhagic complication. We should choose anticoagulation therapy for acute stroke patients with VTE focused on former use of antiplatelet drug and hemorrhagic complication." @default.
- W2896941213 created "2018-10-26" @default.
- W2896941213 creator A5003645130 @default.
- W2896941213 creator A5013650639 @default.
- W2896941213 creator A5017476985 @default.
- W2896941213 creator A5017549075 @default.
- W2896941213 creator A5065217379 @default.
- W2896941213 creator A5087067579 @default.
- W2896941213 date "2018-01-22" @default.
- W2896941213 modified "2023-09-25" @default.
- W2896941213 title "Abstract TP71: One-twentieth of Acute Ischemic Stroke With Anticoagulation Therapy for Venous Thromboembolism Have Hemorrhagic Complications" @default.
- W2896941213 doi "https://doi.org/10.1161/str.49.suppl_1.tp71" @default.
- W2896941213 hasPublicationYear "2018" @default.
- W2896941213 type Work @default.
- W2896941213 sameAs 2896941213 @default.
- W2896941213 citedByCount "1" @default.
- W2896941213 countsByYear W28969412132018 @default.
- W2896941213 crossrefType "journal-article" @default.
- W2896941213 hasAuthorship W2896941213A5003645130 @default.
- W2896941213 hasAuthorship W2896941213A5013650639 @default.
- W2896941213 hasAuthorship W2896941213A5017476985 @default.
- W2896941213 hasAuthorship W2896941213A5017549075 @default.
- W2896941213 hasAuthorship W2896941213A5065217379 @default.
- W2896941213 hasAuthorship W2896941213A5087067579 @default.
- W2896941213 hasConcept C127413603 @default.
- W2896941213 hasConcept C141071460 @default.
- W2896941213 hasConcept C164705383 @default.
- W2896941213 hasConcept C2780645631 @default.
- W2896941213 hasConcept C2780868729 @default.
- W2896941213 hasConcept C2991741193 @default.
- W2896941213 hasConcept C2993316766 @default.
- W2896941213 hasConcept C3020199598 @default.
- W2896941213 hasConcept C541997718 @default.
- W2896941213 hasConcept C71924100 @default.
- W2896941213 hasConcept C78519656 @default.
- W2896941213 hasConceptScore W2896941213C127413603 @default.
- W2896941213 hasConceptScore W2896941213C141071460 @default.
- W2896941213 hasConceptScore W2896941213C164705383 @default.
- W2896941213 hasConceptScore W2896941213C2780645631 @default.
- W2896941213 hasConceptScore W2896941213C2780868729 @default.
- W2896941213 hasConceptScore W2896941213C2991741193 @default.
- W2896941213 hasConceptScore W2896941213C2993316766 @default.
- W2896941213 hasConceptScore W2896941213C3020199598 @default.
- W2896941213 hasConceptScore W2896941213C541997718 @default.
- W2896941213 hasConceptScore W2896941213C71924100 @default.
- W2896941213 hasConceptScore W2896941213C78519656 @default.
- W2896941213 hasIssue "Suppl_1" @default.
- W2896941213 hasLocation W28969412131 @default.
- W2896941213 hasOpenAccess W2896941213 @default.
- W2896941213 hasPrimaryLocation W28969412131 @default.
- W2896941213 hasRelatedWork W1964078180 @default.
- W2896941213 hasRelatedWork W1985057735 @default.
- W2896941213 hasRelatedWork W2020580140 @default.
- W2896941213 hasRelatedWork W2073652779 @default.
- W2896941213 hasRelatedWork W2079192647 @default.
- W2896941213 hasRelatedWork W2088709930 @default.
- W2896941213 hasRelatedWork W2113021651 @default.
- W2896941213 hasRelatedWork W2364874619 @default.
- W2896941213 hasRelatedWork W2380759703 @default.
- W2896941213 hasRelatedWork W2385786597 @default.
- W2896941213 hasRelatedWork W2687998092 @default.
- W2896941213 hasRelatedWork W2806067186 @default.
- W2896941213 hasRelatedWork W2889384345 @default.
- W2896941213 hasRelatedWork W2898378799 @default.
- W2896941213 hasRelatedWork W2997458576 @default.
- W2896941213 hasRelatedWork W3005179545 @default.
- W2896941213 hasRelatedWork W3006333945 @default.
- W2896941213 hasRelatedWork W3025204990 @default.
- W2896941213 hasRelatedWork W3028641895 @default.
- W2896941213 hasRelatedWork W3083969818 @default.
- W2896941213 hasVolume "49" @default.
- W2896941213 isParatext "false" @default.
- W2896941213 isRetracted "false" @default.
- W2896941213 magId "2896941213" @default.
- W2896941213 workType "article" @default.